A population-based study of concurrent prescriptions of opioid analgesic and selective serotonin reuptake inhibitor medications during pregnancy and risk for adverse birth outcomes.
A population-based study of concurrent prescriptions of opioid analgesic and selective serotonin reuptake inhibitor medications during pregnancy and risk for adverse birth outcomes.
复制标题
妊娠期间阿片类镇痛药和选择性5-羟色胺再摄取抑制剂药物的同时处方与不良出生结局风险的人群研究
DOI:
10.1111/ppe.12721
复制
发表时间:
2021-03
影响因子:
2.8
通讯作者:
D'Onofrio BM
中科院分区:
文献类型:
--
作者:
Sujan AC;Rickert ME;Quinn PD;Ludema C;Wiggs KK;Larsson H;Lichtenstein P;Almqvist C;Öberg AS;D'Onofrio BM
Pregnant women with painful conditions often have mental health problems, including depression and anxiety. Comorbid conditions may cause pregnant women to use multiple medications, although safety of such practice is poorly understood. We investigated the influence of combined prescriptions of opioid analgesics and selective-serotonin reuptake inhibitors (SSRIs) during pregnancy on two adverse birth outcomes. We analyzed Swedish population-based births (n=688,914) between 2007 and 2013. Using national registers, we obtained data on filled medication prescriptions, birth outcomes, and a wide range of parental characteristics. We estimated preterm birth and small for gestational age risk following independent or combined prescriptions of the two medications compared with no filled prescriptions for either medication. We adjusted for confounders using inverse probability of treatment weights. After adjusting for confounders, preterm birth risk was higher among women with opioid analgesic prescriptions only (5.9%; risk ratio [RR] 1.27, 95% confidence interval [CI] 1.22, 1.33), SSRIs only (6.2%; RR 1.34, 95% CI 1.27, 1.42), and both medications (7.8%; RR 1.70, 95% CI 1.47, 1.96) compared with unexposed women (4.6%). The interaction between the medications on preterm birth was small (risk difference [RD] 0.4%, 95% CI −0.8%, 1.6%); relative excess risk due to interaction [RERI] 0.09, 95% CI −0.17, 0.34; RR 1.00, 95% CI 0.85, 1.17). For small for gestational age, risk was approximately 2% across all groups, and there was no interaction between the medications (RD 0.3%, 95% CI −0.4%, 1.1%); RERI 0.15, 95% CI −0.16, 0.47; RR 1.15, 95% CI 0.87, 1.52). Compared with unexposed pregnancies, those with either medication alone had a small increased risk for preterm birth but no increased risk for small for gestational age. The magnitude of associations with combined exposure to both medications were not greater than the sum of the associations with each medication considered individually.
登录
查看更多内容
影响因子:
4.2
作者:
Abrahamsson, Tove;Berge, Jonas;Hakansson, Anders
通讯作者:
Hakansson, Anders
影响因子:
17.7
作者:
Fazel, Seena;Grann, Martin
通讯作者:
Grann, Martin
DOI:
10.1177/140349489001800209
发表时间:
1990-01-01
期刊:
SCANDINAVIAN JOURNAL OF SOCIAL MEDICINE
影响因子:
--
作者:
CNATTINGIUS, S;ERICSON, A;KALLEN, B
通讯作者:
KALLEN, B
影响因子:
5
作者:
Cole, Stephen R.;Hernan, Miguel A.
通讯作者:
Hernan, Miguel A.
影响因子:
--
作者:
D'Onofrio, Brian M.;Singh, Amber L.;Iliadou, Anastasia;Lambe, Mats;Hultman, Christina M.;Grann, Martin;Neiderhiser, Jenae M.;Langstrom, Niklas;Lichtenstein, Paul
通讯作者:
Lichtenstein, Paul